Phuong T. Ngo, M.D.

Phuong Ngo, M.D.

Phuong T. Ngo, M.D.

  • Assistant Professor of Medicine
UofL Health - Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments

Clinical Expertise
Oncology; Hematology

Board Certifications

  • American Board of Internal Medicine -
    Internal Medicine / Medical Oncology / Hematology

Education and Training

  • Medical School: St. George's University
  • Residency: Jersey Shore University Medical Center
  • Fellowship: University of Louisville

Featured Publications

  • Kumar R, Chan A, Bandikatla S, Ranjan S, Ngo P. Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders. Curr Probl Cancer. 2022 Aug;46(4):100864. doi: 10.1016/j.currproblcancer.2022.100864. Epub 2022 May 2. PMID: 35671576.
  • Mueller AN, Morrisey S, Miller HA, Hu X, Kumar R, Ngo PT, Yan J, Frieboes HB. Prediction of lung cancer immunotherapy response via machine learning analysis of immune cell lineage and surface markers. Cancer Biomark. 2022;34(4):681-692. doi: 10.3233/CBM-210529. PMID: 35662108.
  • Li Q, Ngo PT, Egilmez NK. Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy. Cancer Immunol Immunother. 2021 Jun;70(6):1789-1796. doi: 10.1007/s00262-020-02795-2. Epub 2020 Nov 27. PMID: 33245376; PMCID: PMC10991855.
  • Ngo P, Shanshal M, Rojan A. Immunotherapy in pancreatic cancer and the importance of tumour testing. BMJ Case Rep. 2020 Jul 16;13(7):e235774. doi: 10.1136/bcr-2020-235774. PMID: 32675128; PMCID: PMC7368477.
  • Bhandari S, Ngo P, Kute B, Mandadi M, Pitman WA, Wu X, Lloyd S, Brown MC, Rai SN, Jain D, Riley EC. Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study. Breast Cancer Res Treat. 2019 Sep;177(2):395-399. doi: 10.1007/s10549-019-05308-7. Epub 2019 Jun 6. PMID: 31172406.
  • Reynolds SB, Hashmi H, Ngo P, Kloecker G. Rescue therapy for acute idiopathic thrombocytopenic purpura unresponsive to conventional treatment. BMJ Case Rep. 2019 Jan 14;12(1):bcr-2018-227717. doi: 10.1136/bcr-2018-227717. PMID: 30642865; PMCID: PMC6340572.